Answer
Symkevi is contraindicated in patients with hypersensitivity to its active substances, tezacaftor or ivacaftor, or to any excipient listed in section 6.1.
Sources for this answer
- Symkevi 100 mg/150 mg tablets PLGB 22352/0003Vertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.3 Contraindications · Version 14Document updated
Sources checked